MARILAO MEDICAL & DIAGNOSTIC CLINIC, INC.

Processed by:
(JONI VILLANUEVA MOLECULAR DIAGNOSTIC
LABORATORY) IGULOT RD., BRGY. IGULOT,
BOCAUE, BULACAN.
Department of Health License No.: 03-0037-2021-CT-2
Contact No. 0931-069-7666

Name: BAUTISTA, DOMAR MARTIN PWMNE-0000237

Age: 27
Sex: Male

. PUROK 5 MANAGOS BAYAMBANG PANGASINAN REGION I

MMDC POBLACION WEST MUÑOZ NUEVA ECIJA

Nasopharyngeal / Oropharyngeal swab

2021-09-21 08:40:00

2021-09-22 06:37:55

PATHOLOGY TEST PERFORMED

SARS – CoV-2 (causative agent of Covid-19) viral RNA detection by Real-Time Reverse Transcription Polymerase Chain Reaction

RESULT: 2021-09-22 06:37:55

SARS-CoV-2 (causative agent of COVID-19)

NOTviralDETECTED
RNA

INTERPRETATION:

NEGATIVE
METHOD: Real-Time Reverse Transcription Polymerase Chain Reaction (qRT-PCR) was performed to test the presence of SARS-CoV-2 viral RNA. RNA
extraction was performed using an automated RNA extraction machine to purify viral RNA in the sample. FDA approved SARS-CoV-2 qRT-PCR reagent kits
were used to detect SARS-CoV-2 specific gene targets (RdRp/N/ORF1ab/NSP-3). Amplification and detection were done using BIORAD CFX96 Real-Time
PCR machine with positive and negative controls included in each run to confirm validity and accuracy of results.
TEST: Qualitative detection of SARS-CoV-2, the causative agent of COVID-19, extracted from nasopharyngeal & oropharyngeal swab samples.
LIMITATION: Pre-analytical variables such as sample collection, storage, handling and transport may affect the quality of results. The detection of viral RNA is
dependent on the viral load if the sample was collected early and/or late in the course of infection. PCR results should not be used as the sole basis of patient

Date of birth (YYYY-MM-DD): 1994-03-24

Address:

Passport #: N/A
Hospital/LGU:
Specimen type:
Lab ID: 0132335
Specimen ID: PWMNE-0000237
Mobile No.: 09673267567
 Nationality: FILIPINO
Date & time of collection (YYYY-MM-DD/HH:MM:SS):
Date & Time of receipt in the lab (YYYY-MM-DD/HH:MM:SS): 2021-09-21 22:52:33 Date
& Time release of results (YYYY-MM-DD/HH:MM:SS):

Molecular Diagnostic Test

....

treatment management decision. PCR results should be interpreted by a physician in conjunction with review of patient’s history and clinical signs and
symptoms.
QUALITY ASSURANCE: MMDC is comprised of trained laboratory personnel in performing molecular diagnostic assays and passed the external proficiency
testing conducted by the Department of Health – Research Institute for Tropical Medicine.

BAUTISTA

Powered by TCPDF (www.tcpdf.org)